SEER is an authoritative source of information on cancer incidence and survival in the United States. SEER currently collects and publishes cancer incidence and survival data from population-based cancer registries covering approximately 28 percent of the U.S. population.
Lymph nodes (C770-C779) are the usual primary sites; however, involvement in other sites is possible. If you have confirmation that the only involved site is something other than the lymph nodes, then code to that primary site. See Module 7
Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) commonly involves cervical, axillary, or inguinal lymph nodes. Mediastinal, splenic, and bone marrow involvement are rare.
Most patients present with localizedperipherallymphadenopathy (stage I or II). 5-25% of patients present with advanced stage disease.
The disease is usually responsive to therapy and thus is rarely fatal.
In some countries (France) stage I disease is not treated, especially in children, after resection of the affectedlymph nodes.
For more information on this neoplasm, see the NCI website: http://www.cancer.gov/types/lymphoma/hp/adult-hodgkin-treatment-pdq or http://www.cancer.gov/types/lymphoma/patient/adult-hodgkin-treatment-pdq